Overview

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso...

Open

$0.00

Prior close

$497.27

Today's high

$0.00

Today's low

$0.00

52 Week high

$609.35

52 Week low

$402.50

News

Schaeffers Research • 19 hours ago • UTHR

Biotech Options Buzz: UTHR, NMRA, EWTX

Seeking Alpha • 4 days ago • UTHR

United Therapeutics Corporation (UTHR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • 9 days ago • UTHR

United Therapeutics Corporation (UTHR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Seeking Alpha • 10 days ago • UTHR

United Therapeutics Corporation (UTHR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Business Wire • 11 days ago • UTHR

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization